Brief: Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results And Provides Corporate Update
April 5 (Reuters) - Sunshine Biopharma Inc SBFM.O :
* SUNSHINE BIOPHARMA REPORTS FULL YEAR ENDED DECEMBER 31,
2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* SUNSHINE BIOPHARMA INC - FULL YEAR 2022 CASH AND CASH AND
CASH
EQUIVALENTS OF $21 MILLION
Source text for Eikon: ID:nGNX9tHvGb
Further company coverage: SBFM.O
((Reuters.Briefs@thomsonreuters.com;))